HRAS and breast carcinoma: According to what found in other tumor types, KRAS confirms to be the most frequently mutated RAS isoform in breast cancer (Figure 2A) and its mutation, unlike mutations of HRAS and NRAS, is strongly associated with the poor clinical outcome (Figure 2B).